🏛️ Verified NIH Record • Updated 2026-02-04

Eye Plaque Brachytherapy for Ocular Melanoma (NCT06432660)

Prospective Registry of Ocular Melanoma Eye Plaque brachyTherapy Patients (PROMPT)

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Duke University

🩺 Plain-English Summary (8th-Grade Level)

This prospective registry study will evaluate doses utilized in eye plaque brachytherapy for the treatment of ocular melanoma and their associated outcomes. The goal of this study is to evaluate if lower doses of radiation can maintain high local control rates while minimizing the toxicities related to radiation therapy.

Who can join: Review the eligibility criteria below.

Location: Duke University Medical Center — Durham, North Carolina

Age range: 18 Years

🧪 Interventions in This Study

  • Data collection (OTHER)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

  • Duke University Medical Center — Durham, North Carolina

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Ocular Melanoma clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗